Bicycle Therapeutics PLC (BCYC)
22.18
-0.18
(-0.80%)
USD |
NASDAQ |
May 16, 16:00
22.16
-0.02
(-0.11%)
Pre-Market: 20:00
Bicycle Therapeutics Cash and Short Term Investments (Quarterly): 457.00M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 457.00M |
| December 31, 2023 | 526.42M |
| September 30, 2023 | 572.09M |
| June 30, 2023 | 340.43M |
| March 31, 2023 | 293.82M |
| December 31, 2022 | 339.15M |
| September 30, 2022 | 361.47M |
| June 30, 2022 | 372.77M |
| March 31, 2022 | 407.37M |
| December 31, 2021 | 438.68M |
| September 30, 2021 | 259.52M |
| Date | Value |
|---|---|
| June 30, 2021 | 198.74M |
| March 31, 2021 | 195.90M |
| December 31, 2020 | 135.99M |
| September 30, 2020 | 149.84M |
| June 30, 2020 | 96.91M |
| March 31, 2020 | 109.64M |
| December 31, 2019 | 92.12M |
| September 30, 2019 | 95.95M |
| June 30, 2019 | 108.54M |
| March 31, 2019 | 59.37M |
| December 31, 2018 | 63.38M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
92.12M
Minimum
Dec 2019
572.09M
Maximum
Sep 2023
277.62M
Average
276.67M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 7.606M |
| NuCana PLC | 21.94M |
| TC BioPharm (Holdings) PLC | 3.137M |
| Adaptimmune Therapeutics PLC | 146.94M |
| Verona Pharma PLC | 254.88M |